Longitudinal myelitis associated with yellow fever vaccination

Journal of NeuroVirology

Volumn 15, Issue 4, 2009, Pages 348-350

  Chaves, M ^a   Riccio, P ^a   Patrucco, L ^a   Rojas, Ji ^a   Cristiano, E ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Myelitis; Neurological adverse events; South America; Vaccine; Yellow fever

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; YELLOW FEVER VACCINE; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADULT; ARGENTINA; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CONSTIPATION; CONTRAST ENHANCEMENT; FLAVIVIRUS; HOSPITAL ADMISSION; HUMAN; IMMUNIZATION; LEG; LEUKOCYTE; LIMB WEAKNESS; LONGITUDINAL MYELITIS; MALE; MUSCLE STRENGTH; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PARESTHESIA; PLEOCYTOSIS; PRIORITY JOURNAL; REHABILITATION CARE; SEROLOGY; SOUTH AMERICA; URINE RETENTION; YELLOW FEVER; ADVERSE EFFECTS; IMMUNOLOGY; MIDDLE AGED; MYELITIS, TRANSVERSE; VACCINATION; YELLOW FEVER VIRUS;

ANTIBODIES, VIRAL; ARGENTINA; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; VACCINATION; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

FLAVIVIRUS;

EID: 70450237702     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280903062805     Document Type: Article

References (9)

1. Cetron MS, Marfin AA, Julian KG, et al (2002). Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 51(RR-17):1-11; quiz CE1-4.
2. Fernandes GC, Camacho LA, Sa Carvalho M, Batista M, de Almeida SM (2007). Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. Vaccine 25: 3124-3128.
3. Iskander JK, Miller ER, Chen RT (2004). The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety. Pediatr Ann 33: 599-606.
4. Kitchener S (2004). Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX. Vaccine 22: 2103-2105.
5. Lindsey NP, Schroeder BA, Miller ER, et al (2008). Adverse event reports following yellow fever vaccination. Vaccine 26: 6077-6082.
6. McMahon AW, Eidex RB, Marfin AA, et al (2007). Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine 25: 1727-1734.
7. Monath, TP (2004). Yellow Fever Vaccine. In Vaccines, ed. SA Plotkin and WA Orenstein, 1095-1176. Philadelphia: Saunders.
8. Sanders EJ, Marfin AA, Tukei PM, et al (1998). First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. Am J Trop Med Hyg 59: 644-649.
9. Varricchio F, Iskander J, Destefano F, et al (2004). Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 23: 287-294. (Pubitemid 38508877)